Associate Professor
Urology
Dr. Stephen J. Freedland, MD
|
|
Give Review
Stephen Freedland works in the field of Urology. He went to University of California Davis School of Medicine. University of California Davis School of Medicine has a rank of 43 in research and a 19 in primary care He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Stephen J. Freedland, MD is a published doctor and has 16 publications published. The lastest was: 'Evaluation of an epithelial plasticity biomarker panel in men with localized prostate cancer.'
Publications
- Evaluation of an epithelial plasticity biomarker panel in men with localized prostate Cancer.
- Predicting bone scan positivity after biochemical recurrence following radical Prostatectomy in both hormone-naive men and patients receiving androgen-deprivation ther...
- Association between systemic inflammatory markers and serum Prostate-specific antigen in men without prostatic disease-The 2001-2008 National Health and Nutrition exam...
- Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate Cancer, and mortality after radical...
- Metformin does not affect risk of biochemical recurrence following radical Prostatectomy: results from the SEARCH database.
- Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate Cancer risk in a multiethnic study.
- A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate Cancer before radical prostatectomy.
- Prognostic utility of cell cycle progression score in men with prostate Cancer after primary external beam radiation therapy.
- Autonomic nerve development contributes to prostate Cancer progression.
- Fish oil slows prostate Cancer xenograft growth relative to other dietary fats and is associated with decreased mitochondrial and insulin pathway gene expression.
- Identifying Appropriate Patients for Early Salvage Radiotherapy after Prostatectomy.
- Statin use and risk of prostate Cancer and high-grade prostate Cancer: results from the REDUCE study.
- Race is associated with discontinuation of active surveillance of low-risk prostate Cancer: results from the Duke Prostate Center.
- The relationship between prostate-specific antigen and prostate Cancer risk: the Prostate Biopsy Collaborative Group.
- Case scenario: 69-year-old male with left spermatic cord mass.
Schools
University of California At Irvine California College of Medicine amp Surgery
Procedures Preformed
- Cystometry
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Orchiectomy
- Prostate Removal
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- Blood in Urine (Hematuria)
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
UCLA Medical Center -
University of California Davis School of Medicine
Hospital
-
Duke University Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Michael A. Granieri, MD |
|
|
Dr. Arthur W. Whitehurst, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher Tepera, MD
This Doctor is OpenDoctor Recommended.
|